Recruiting studies: Mci Due To Ad

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)
Phase N/A · 1 location(s) · VA Office of Research and Development · NCT04124029 A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Phase 3 · 143 location(s) · Hoffmann-La Roche · NCT07169578 Mindfulness for Cognition in Early-stage Alzheimer's Disease
NA · 1 location(s) · VA Boston Healthcare System · NCT06792877 Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's D
Phase 2 · 1 location(s) · Medical University of Lodz · NCT06850597 Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)
Phase N/A · 1 location(s) · Chinese PLA General Hospital · NCT07089303 Language, Speech and Motor Function in MCI Due to AD and Alzheimer's Disease
Phase N/A · 1 location(s) · Hanze University of Applied Sciences Groningen · NCT06508268 An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease
Phase 3 · 2 location(s) · University College, London · NCT07724132 A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Phase 3 · 150 location(s) · Hoffmann-La Roche · NCT07170150 Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study
NA · 1 location(s) · Cedars-Sinai Medical Center · NCT07224607

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.